Other languages ABVC BioPharma, Inc.

Equities

ABVC

US00091F3047

Market Closed - Nasdaq Other stock markets 04:30:00 2024-06-06 pm EDT			5-day change	1st Jan Change
0.789 ^USD	+1.65%		-8.04%	-31.98%

May. 09	Abvc Biopharma, Inc. Enters into A Definitive Agreement with Oncox Biopharma, Inc	CI
Apr. 10	ABVC BioPharma, Inc., BioLite, Inc. and Rgene Corporation Enter Term Sheet with OncoX BioPharma, Inc	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Abvc Biopharma, Inc. Enters into A Definitive Agreement with Oncox Biopharma, Inc	May. 09
ABVC BioPharma, Inc., BioLite, Inc. and Rgene Corporation Enter Term Sheet with OncoX BioPharma, Inc	Apr. 10
ABVC BioPharma, Inc. and BioFirst Corporation Enter Global Licensing Agreement with ForSeeCon Eye Corporation	Mar. 26
ABVC BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 13
ABVC BioPharma Signs Licensing Deal With Senior Paradise	Feb. 15
ABVC BioPharma, Inc. Executes a Definitive Agreement to Receive License Fees of $3 Million and Royalties of 2% on Future Revenue	Feb. 15
Top Premarket Decliners	Jan. 04
Sector Update: Health Care Stocks Mixed Late Afternoon	Jan. 03
Sector Update: Health Care	Jan. 03
Traders Anticipate Fed Minutes as US Equity Futures Decline Pre-Bell	Jan. 03
Top Midday Gainers	Jan. 03
ABVC BioPharma, Inc. Announces Completion of Subject Treatment for Interim Analysis on ADHD Phase IIb Clinical Study	Dec. 07
ABVC BioPharma, Inc. Enters Definitive Agreement with Licensing Income Worth $467 Million and Royalties Up to $200 Million	Nov. 16
ABVC BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 15
Wall Street Set to Open Lower as GDP, Jobless Claims Higher Than Expected	23-10-26
ABVC BioPharma Enters Into a Term Sheet to License Global Rights of CNS Drugs with the Indications of MDD and ADHD to AiBtl BioPharma at the Valuation of $667 Million	23-10-26
Abvc Biopharma, Inc. Announces Completion of Subject Recruitment for Interim Analysis on Adhd Phase Iib Clinical Study	23-10-17
Top Premarket Gainers	23-09-15
ABVC BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
ABVC BioPharma, Inc. Announces the Approval of the Plan for GMP Production Facilities of Vitargus by Taiwan Science Park Administration	23-08-03

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages ABVC BioPharma, Inc.

Equities

ABVC

US00091F3047

Other languages

Filters